Sales by 10% owner entities at this scale are routine and do not signal deteriorating fundamentals. Monitor the next 10-Q for any change in Lantheus's ownership stake or strategic intent, but no immediate trading action is warranted.
Price Chart
Executive Summary
Two 10% owner entities of Perspective Therapeutics (Lantheus Holdings, Inc. and Lantheus Alpha Therapy, LLC) sold a combined ~116.6K shares in open-market transactions totaling ~$362K over a three-day window. The sales are modest in absolute dollar terms and represent a trivial fraction of the company's market cap, suggesting routine portfolio rebalancing rather than a negative signal on the company's prospects.
Key Financial Metrics
Key Facts
- Two 10% owner entities (Lantheus Holdings, Inc. and Lantheus Alpha Therapy, LLC) sold a combined ~116,600 shares in open-market transactions.
- Total sale value: approximately $362,000 across three days (Sep 1–3, 2026).
- All sales were open-market (code S) with no 10b5-1 plan indication in the provided data.
- No C-suite officers or directors participated in the cluster; only 10% owner entities sold.
- The dollar value is trivial relative to the company's market cap (~$326M), representing ~0.11% of market cap.
Financial Impact
Total insider sales of ~$362K, or ~0.11% of market cap — immaterial.
Risk Factors
- If Lantheus continues to sell in subsequent weeks, the pattern could indicate a strategic reduction in the stake.
- No C-suite buying to offset the selling — a lack of insider confidence signal, though not a bearish one at this size.
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CATX-1788900725037 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $1.61 | awaiting T+20 | — | $1.21 (−24.84%) |
Oct 8, 2026 19d ago | 8-K | $2.71 | awaiting T+20 | — | $1.21 (−55.35%) |
Oct 2, 2026 24d ago | Press Release | $2.76 | awaiting T+20 | — | $1.21 (−56.16%) |
Sep 14, 2026 6w ago | 8-K | $2.92 $2.52 | ▼ −13.70% | ▼ −15.96% | $1.21 (−58.56%) |
Sep 11, 2026 6w ago | Press Release | $2.81 $2.66 | ▼ −5.34% | ▼ −7.21% | $1.21 (−56.94%) |
Sep 8, 2026 6w ago | Insider Cluster | $2.99 $2.46 | ▼ −17.73% | ▼ −19.67% | $1.21 (−59.53%) |
Sep 4, 2026 7w ago | Insider Cluster | $3.12 $2.36 | ▼ −24.36% | ▼ −26.07% | $1.21 (−61.22%) |
Sep 4, 2026 7w ago | Insider Cluster | $3.12 $2.36 | ▼ −24.36% | ▼ −26.07% | $1.21 (−61.22%) |
Aug 10, 2026 11w ago | 8-K | $3.18 $2.99 | ▼ −5.97% | ▼ −4.92% | $1.21 (−61.95%) |
Jul 17, 2026 14w ago | Press Release | $2.99 $3.20 | ▲ +7.02% | ▲ +2.58% | $1.21 (−59.53%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers